Oxford Vaccine At Rs 1,000 If Centre Allows Us To Sell: Adar Poonawalla | Read

  • 1:32
  • Published On: January 04, 2021
Cinema View
Embed
The Serum Institute of India's Covishield vaccine, which has got approval from the country's drug regulator, will be commercially available at Rs 1,000 per dose if the government allows sale in retail, company chief Adar Poonawalla has said. For the government, "We are giving it in a very special price of Rs 200 for the first hundred million doses. Then there will be tendering and then different prices will be available," Mr Poonawalla told NDTV.

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-Effect
May 05, 2024 4:27
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
April 30, 2024 2:48
"A Very Big Source Of Covid Vaccines For World": Bill Gates Praises India
February 29, 2024 3:21
'Poverty Associated With Long Covid': Dr Soumya Swaminathan
February 19, 2024 6:52
What Does Covid-19 Do To Your Lungs?
February 19, 2024 22:46
"This Was Expected": Karnataka Health Minister On JN.1 Cases In State
December 25, 2023 3:57
Maharashtra Reports 50 New COVID-19 Cases, 9 Of Them JN.1 Infections
December 25, 2023 0:46
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination